Lemaitre Vascular (LMAT) Tops Q4 EPS by 3c, Beats on Revenue; Offers FY25 Guidance

February 27, 2025 4:28 PM EST

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.49, $0.03 better than the analyst estimate of $0.46. Revenue for the quarter came in at $55.7 million versus the consensus estimate of $55.49 million.

GUIDANCE:

Lemaitre Vascular sees FY2025 EPS of $2.15-$2.32, versus the consensus of $2.16. Lemaitre Vascular sees FY2025 revenue of $235.4-242.8 million, versus the consensus of $240.2 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK